Filter Search


Healthcare and Medical


Location Summary Deadline
Germany The Subject Of This Publication Is The Conclusion Of Non-exclusive Discount Contracts In Accordance With § 130a Abs. 8 Sgb V For Finished Medicinal Products Containing The Active Ingredient Tafluprost (atc: S01ee05) Within The Framework Of A So-called ''o 2026-06-10
Germany Conclusion Not Excluding The Discount Agreement For Medicinal Products According To § 130a Para. 8 Sgb V By Means Of An Open House Model For The Active Ingredient Betahistine (atc Code According To Who 2026-06-10
Germany Conclusion Of Non-exclusive Discount Agreements According To § 130a Para. 8 Sgb V For The Mentioned Active Ingredients With The Possibility Of Conclusion Within The Framework Of The So-called Open House Procedure. 2026-06-10
Germany Conclusion Of Non-exclusive Discount Agreements According To § 130a Para. 8 Sgb V For The Mentioned Active Ingredients With The Possibility Of Conclusion Within The Framework Of The So-called Open House Procedure. 2026-06-10
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V For Pharmaceuticals Containing The Active Ingredient Pamidronic Acid (atc Code 2026-06-10
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V For Pharmaceuticals Containing The Active Ingredient Propranolol (atc Code 2026-06-10
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Formoterol + Beclometasone (exclusively Dafo. Ihp, Inhalation), Atc R03ak08 For The Period 01.01.2026 To 31.12.2027 2026-06-10
Paraguay Acquisition Of Tools, Devices And Instruments In General 2026-06-11
Germany Open House Drug Discount Agreements For The Active Ingredients Naproxen And Esomeprazole, Atc M01ae52, 67304 Eisenberg Rhineland-palatinate 2026-06-11
Germany Open House Drug Discount Agreements For The Active Ingredient Repaglinide, Atc A10bx02, 67304 Eisenberg Rhineland-palatinate 2026-06-11
Whats app